Kolschowsky Research and Education Institute at Sarasota Memorial Hospital is seeking candidates diagnosed with ...

Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.

ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...

Urothelial carcinoma is a multifaceted malignancy that includes non–muscle-invasive bladder cancer (NMIBC) and upper tract ...

A diagnosis of adenocarcinoma of the bladder requires careful and specialized care. Because it is rare, it is essential to be treated by a multidisciplinary team, including a urologic oncologist, ...

UI Health Care researchers designed a new device to improve convenience and quality of life for bladder cancer patients undergoing chemotherapy. About the size of a dime, the device floats in the ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort and clinical outcomes. Researchers have found that examining certain patter ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract ...

Photocure ASA ( ($PHCUF) ) has provided an announcement. Photocure ASA presented findings from the BRAVO study at the Society of Urologic Oncology ...